Compare TU & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TU | ZBH |
|---|---|---|
| Founded | 1993 | 1927 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Industrial Specialties |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0B | 18.7B |
| IPO Year | N/A | N/A |
| Metric | TU | ZBH |
|---|---|---|
| Price | $13.63 | $87.78 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 21 |
| Target Price | $18.17 | ★ $107.40 |
| AVG Volume (30 Days) | ★ 4.9M | 1.9M |
| Earning Date | 02-12-2026 | 02-10-2026 |
| Dividend Yield | ★ 8.86% | 1.11% |
| EPS Growth | ★ 24.25 | N/A |
| EPS | 0.56 | ★ 4.03 |
| Revenue | ★ $14,679,551,147.00 | $8,010,900,000.00 |
| Revenue This Year | $2.94 | $7.98 |
| Revenue Next Year | $2.40 | $5.16 |
| P/E Ratio | $24.04 | ★ $21.46 |
| Revenue Growth | 2.42 | ★ 5.47 |
| 52 Week Low | $12.54 | $85.33 |
| 52 Week High | $16.74 | $114.44 |
| Indicator | TU | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 60.20 | 40.97 |
| Support Level | $13.27 | $85.83 |
| Resistance Level | $13.64 | $89.00 |
| Average True Range (ATR) | 0.19 | 2.80 |
| MACD | 0.06 | -0.41 |
| Stochastic Oscillator | 94.72 | 20.72 |
Telus is one of the Big Three wireless service providers in Canada, with over 10 million mobile phone subscribers nationwide constituting almost 30% of the total market. It is the incumbent local exchange carrier in the western Canadian provinces of British Columbia and Alberta, where it provides internet, television, and landline phone services. It also has a small wireline presence in eastern Quebec. Mostly because of recent acquisitions, more than 20% of Telus' sales now come from nontelecom businesses, most notably in the international business services, health, security, and agriculture industries. The firm has a 55% economic stake in Telus International.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.